March-April 2023
Interventions and Assessments
- HEAR DR AYANA JORDAN ON EPISODE 2 OF "BEHIND THE EVIDENCE," OUR NEW PODCAST
- Receipt of Lisdexamphetamine Associated With Decreased Risk of Hospitalization and Death in a Cohort of People With Stimulant Use Disorder
Health Outcomes
- Relaxed Federal Methadone Take-home Policy Not Associated With Methadone-related Deaths
- Benzodiazepine Use Did Not Have an Adverse Impact on Treatment Retention in an Open-access Methadone Program
- Prior Authorization Policies Are Associated With Shorter Duration of Buprenorphine Treatment
- Screening, Brief Intervention, and Referral to Treatment in Adolescence Provides Lasting Benefit into Young Adulthood
- Alcohol Use Patterns in Adolescence Associated With Alcohol and Other Drug Overdose in Adulthood
- Receipt of Buprenorphine in Pregnancy Associated With a Lower Risk of Adverse Neonatal Outcomes Than Methadone
- Most Current Guidelines for the Treatment of Infective Endocarditis Fall Short of Evidence-based Treatment for Opioid Use Disorder